ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer. - Wikidata - awgldk - TriplyDB

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.

http://www.wikidata.org/entity/Q37711691

about

Imaging tumor metabolism using positron emission tomography Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production.Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.Attacking the supply wagons to starve cancer cells to death.The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.PET in the management of locally advanced and metastatic NSCLC.Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.System A amino acid transporters regulate glutamine uptake and attenuate antibody-mediated arthritis.STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma.Comparative virulence of in vitro-cultured primate- and pig-associated Helicobacter suis strains in a BALB/c mouse and a Mongolian gerbil model.Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.Structure and allosteric inhibition of excitatory amino acid transporter 1.Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer.Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2 An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models

P2860

Q28085278-AF17023E-2BE4-471C-90BB-6578B371B283 Q33425130-F880AE48-8D80-4EBE-9569-41F054FCA6EF Q33665354-B4E538B8-8B88-43B0-B578-4DA8FF2EA7C8 Q34371526-A4325CC5-DC30-4DC6-8459-D3D306AB5D88 Q34488445-57F718A2-D062-44FF-867D-EDE208FFB376 Q34516773-7386F527-3350-4C27-BE5A-EE05867D7888 Q35095549-E66F4E80-11A3-4CC8-B692-10DB5F41BEF6 Q35440166-C4FFE376-A368-48EA-906E-2AE868D9F949 Q35461825-0F7412F1-2F6B-4578-9D0F-0EB33CA093DA Q35889733-D694E786-821E-47AD-A8AD-E81933918E95 Q35941321-FBECB8AE-19B9-4798-9525-7E83A292C9ED Q35941337-0F56321E-CB24-4D91-B769-6F8EFB7DBF69 Q36236396-C756413F-0359-4B22-A7B6-1A6C19082299 Q36310209-ED2BB691-E87C-4C54-8D46-DFBC7A68D994 Q37448247-ED181B63-DA6A-47EF-B805-DCFDA49BCA66 Q38243334-1ED680F1-E660-4713-943A-31C719CD44AF Q38444980-F927F6BD-F664-444F-BAAE-15F18D766D5D Q38592248-8551C751-10BF-4B1E-ADBD-86BD84C3FC56 Q38651973-94074347-E0D6-48B6-BC38-BC91090F7235 Q38772674-CEAB7059-BE1C-46C8-A45A-E77BAF2634DB Q38837199-AB4341E4-BADF-4191-9B51-562210E7F2E7 Q39021056-1CA89F0B-1EEE-453B-A19F-C73A7E3FDADD Q40564087-92481198-0658-4020-B33B-FA087303E81C Q41143898-5DF33D68-1B00-4C37-8704-F89B92409224 Q41573099-F99534E6-1186-4514-BA0F-D304E8F15E13 Q42356946-245BF1AB-B9BE-4B06-9F13-A3BE1F9AEE9C Q42375237-209CBE20-2FBB-4126-84C6-3EF86F2BF05B Q48277237-E072B56E-4CD1-44D6-892C-DF4F334A9E28 Q57174877-22269D09-C648-455F-B5FA-D03FBB3D2089 Q58804578-857BD723-89D2-439D-8207-B65DFA560545

P2860

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.

http://www.wikidata.org/entity/Q37711691

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

ASC amino-acid transporter 2 ( ...... in non-small cell lung cancer.

@en

ASC amino-acid transporter 2

@nl

type

label

ASC amino-acid transporter 2 ( ...... in non-small cell lung cancer.

@en

ASC amino-acid transporter 2

@nl

prefLabel

ASC amino-acid transporter 2 ( ...... in non-small cell lung cancer.

@en

ASC amino-acid transporter 2

@nl

P1433

Q37711691-B0FB90BB-C76C-45F2-9F21-FE3397E3C1AB

P1476

Q37711691-C43F6B5D-EEC8-4D29-BEE8-03884320CF95

P2093

Q37711691-0547D5AA-5B8C-45F7-89F2-F2B5BE7FEC94

Q37711691-1521ADE5-DBF0-486B-90B0-BD68A2C93A96

Q37711691-18DD4C8D-55C1-469C-BA70-7AE63092578D

Q37711691-1B7B02B2-84FC-4C2C-A622-CA45A9A38A58

Q37711691-2597E9DC-A88B-480B-901A-891667CE49F8

Q37711691-4E7D3D0E-494D-46B3-A0CB-4CBF5F39D23C

Q37711691-4ECA0C39-59D9-4B58-AD27-F1D33430EBB1

Q37711691-94491B18-6BAA-4A5D-B601-ECBDED19BD3E

Q37711691-B310509C-0A9A-47C4-9149-CC6B1A17C834

Q37711691-C382F1F1-62E2-4420-8E35-8A66FA575F0A

P2860

Q37711691-0D52EEFC-D47A-40E9-B841-6AF7F90E45A0

Q37711691-2FD835F8-58CB-4154-A642-16EEEEC94CE0

Q37711691-380B48CC-9E1E-4060-9D8B-1B2C2D5591E3

Q37711691-38C57213-DDA9-4740-B126-6D2977C4D328

Q37711691-3C429879-9172-455C-9C22-1DD44F7B7358

Q37711691-42E3C087-73D7-435B-ABF8-21EB1BBC2D24

Q37711691-486FAAA4-75F3-4F36-B8D6-7835ADA44F8C

Q37711691-56FBA73F-F775-4E3B-B6CB-10E508E79CAA

Q37711691-61ADCCF0-18FB-4577-820E-BEE12C84EC60

Q37711691-625E8A41-5833-4446-B742-3702B48DDAF9

P2888

Q37711691-4BC0043F-30CA-4FF0-804A-9BE297928995

P304

Q37711691-80EDA544-7916-437D-9954-3A0DBF4A1A91

P31

Q37711691-2F039EBE-E174-4E69-A70D-6337D160471C

P356

Q37711691-D9C83F7E-895E-4E76-8F26-AB001CAD6440

P407

Q37711691-053C4B65-001A-49D0-AE9E-C22A088D9DEB

P433

Q37711691-FA508036-B6F2-4DC1-BCB0-D7083D07FF1D

P478

Q37711691-D1E202DF-FF40-41A5-89D0-807797D99F2D

P577

Q37711691-AE4AE4EE-4DF2-43BA-BD49-5D8AA4041C2A

P5875

Q37711691-827A06C3-8BCD-493E-B88C-AA358EAE5E77

P698

Q37711691-6E239893-C85F-41AD-922E-78B6CBABE590

P932

Q37711691-95FD0D80-E965-4C44-A062-D8A21FBA1759

P356

P1433

British Journal of Cancer

P1476

ASC amino-acid transporter 2 ( ...... in non-small cell lung cancer.

@en

P2093

H Tominaga

http://www.w3.org/2001/XMLSchema#string

I Takeyoshi

http://www.w3.org/2001/XMLSchema#string

K Kaira

http://www.w3.org/2001/XMLSchema#string

K Shimizu

http://www.w3.org/2001/XMLSchema#string

M Yamada

http://www.w3.org/2001/XMLSchema#string

N Oriuchi

http://www.w3.org/2001/XMLSchema#string

N Sunaga

http://www.w3.org/2001/XMLSchema#string

O Kawashima

http://www.w3.org/2001/XMLSchema#string

S Nagamori

http://www.w3.org/2001/XMLSchema#string

T Oyama

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer

Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis

Revisions in the International System for Staging Lung Cancer

Identification and characterization of a novel member of the heterodimeric amino acid transporter family presumed to be associated with an unknown heavy chain

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)

L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.

Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.

Prognostic factors in non-small cell lung cancer: a decade of progress.

L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.

P2888

P304

2030-2039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.88

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260610396

http://www.w3.org/2001/XMLSchema#string

P698

24603303

http://www.w3.org/2001/XMLSchema#string

P932

3992511

http://www.w3.org/2001/XMLSchema#string